# | Filing Date | Period End Date | Type | Report Link |
---|---|---|---|---|
No Data found |
# | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
---|
Augmedix (NASDAQ:AUGX) reported quarterly losses of $(0.16) per share which missed the analyst consensus estimate of $(0.13) by...
Lake Street analyst Brooks O'Neil downgrades Augmedix (NASDAQ:AUGX) from Buy to Hold.
Augmedix to be acquired by Commure, Inc. for $139 million in equity. Augmedix stockholders to receive $2.35 per share. The acqu...